These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 15709484)

  • 1. Clusterin and Alzheimer's disease.
    Calero M; Rostagno A; Frangione B; Ghiso J
    Subcell Biochem; 2005; 38():273-98. PubMed ID: 15709484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein J (clusterin) and Alzheimer's disease.
    Calero M; Rostagno A; Matsubara E; Zlokovic B; Frangione B; Ghiso J
    Microsc Res Tech; 2000 Aug; 50(4):305-15. PubMed ID: 10936885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paradigm shifts in Alzheimer's disease and other neurodegenerative disorders: the emerging role of oligomeric assemblies.
    Kirkitadze MD; Bitan G; Teplow DB
    J Neurosci Res; 2002 Sep; 69(5):567-77. PubMed ID: 12210822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between multifunctional protein "clusterin" and Alzheimer disease.
    Choi-Miura NH; Oda T
    Neurobiol Aging; 1996; 17(5):717-22. PubMed ID: 8892344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How a cell deals with abnormal proteins. Pathogenetic mechanisms in protein aggregation diseases.
    Aigelsreiter A; Janig E; Stumptner C; Fuchsbichler A; Zatloukal K; Denk H
    Pathobiology; 2007; 74(3):145-58. PubMed ID: 17643060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small heat-shock proteins and clusterin: intra- and extracellular molecular chaperones with a common mechanism of action and function?
    Carver JA; Rekas A; Thorn DC; Wilson MR
    IUBMB Life; 2003 Dec; 55(12):661-8. PubMed ID: 14769002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chapter 6: The chaperone action of Clusterin and its putative role in quality control of extracellular protein folding.
    Wyatt A; Yerbury J; Poon S; Dabbs R; Wilson M
    Adv Cancer Res; 2009; 104():89-114. PubMed ID: 19878774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased clusterin (apolipoprotein J) expression in human and mouse brains infected with transmissible spongiform encephalopathies.
    Sasaki K; Doh-ura K; Ironside JW; Iwaki T
    Acta Neuropathol; 2002 Mar; 103(3):199-208. PubMed ID: 11907798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clusterin promotes amyloid plaque formation and is critical for neuritic toxicity in a mouse model of Alzheimer's disease.
    DeMattos RB; O'dell MA; Parsadanian M; Taylor JW; Harmony JA; Bales KR; Paul SM; Aronow BJ; Holtzman DM
    Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10843-8. PubMed ID: 12145324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-amyloid treatment of two complementary P301L tau-expressing Alzheimer's disease models reveals similar deregulated cellular processes.
    David DC; Ittner LM; Gehrig P; Nergenau D; Shepherd C; Halliday G; Götz J
    Proteomics; 2006 Dec; 6(24):6566-77. PubMed ID: 17111439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transplanted astrocytes internalize deposited beta-amyloid peptides in a transgenic mouse model of Alzheimer's disease.
    Pihlaja R; Koistinaho J; Malm T; Sikkilä H; Vainio S; Koistinaho M
    Glia; 2008 Jan; 56(2):154-63. PubMed ID: 18004725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice.
    van Groen T; Kiliaan AJ; Kadish I
    Neurobiol Dis; 2006 Sep; 23(3):653-62. PubMed ID: 16829076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amino acid sequence determinants and molecular chaperones in amyloid fibril formation.
    Nerelius C; Fitzen M; Johansson J
    Biochem Biophys Res Commun; 2010 May; 396(1):2-6. PubMed ID: 20494101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Environmental enrichment reduces Abeta levels and amyloid deposition in transgenic mice.
    Lazarov O; Robinson J; Tang YP; Hairston IS; Korade-Mirnics Z; Lee VM; Hersh LB; Sapolsky RM; Mirnics K; Sisodia SS
    Cell; 2005 Mar; 120(5):701-13. PubMed ID: 15766532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein-misfolding diseases and chaperone-based therapeutic approaches.
    Chaudhuri TK; Paul S
    FEBS J; 2006 Apr; 273(7):1331-49. PubMed ID: 16689923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain uptake of circulating apolipoproteins J and E complexed to Alzheimer's amyloid beta.
    Zlokovic BV; Martel CL; Mackic JB; Matsubara E; Wisniewski T; McComb JG; Frangione B; Ghiso J
    Biochem Biophys Res Commun; 1994 Dec; 205(2):1431-7. PubMed ID: 7802679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased clusterin expression in old but not young adult S100B transgenic mice: evidence of neuropathological aging in a model of Down Syndrome.
    Shapiro LA; Marks A; Whitaker-Azmitia PM
    Brain Res; 2004 Jun; 1010(1-2):17-21. PubMed ID: 15126113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stress proteins in Alzheimer's disease.
    Smith RC; Rosen KM; Pola R; Magrané J
    Int J Hyperthermia; 2005 Aug; 21(5):421-31. PubMed ID: 16048839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The beta-amyloid protein of Alzheimer's disease increases neuronal CRMP-2 phosphorylation by a Rho-GTP mechanism.
    Petratos S; Li QX; George AJ; Hou X; Kerr ML; Unabia SE; Hatzinisiriou I; Maksel D; Aguilar MI; Small DH
    Brain; 2008 Jan; 131(Pt 1):90-108. PubMed ID: 18000012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Globular amyloid beta-peptide oligomer - a homogenous and stable neuropathological protein in Alzheimer's disease.
    Barghorn S; Nimmrich V; Striebinger A; Krantz C; Keller P; Janson B; Bahr M; Schmidt M; Bitner RS; Harlan J; Barlow E; Ebert U; Hillen H
    J Neurochem; 2005 Nov; 95(3):834-47. PubMed ID: 16135089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.